{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/622b8f5080a3a00013890f23/66a81c5682b12a8d9a2ce2cc?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Tuesday, July 30, 2024","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/622b8f5080a3a00013890f23/1722293286375-7a6c1171-b35d-4e57-8085-025120d36876.jpeg?height=200","description":"<p>Guardant Health’s blood screening test for colorectal cancer receives federal approval.&nbsp;The FDA warns about dosing errors tied to compounded versions of GLP-1 drugs.&nbsp;And a new study shows that a blood test can accurately diagnose Alzheimer’s disease.&nbsp;That’s coming up on today’s episode of Gist Healthcare Daily.&nbsp;</p>","author_name":"Gist Healthcare Daily"}